|Overview of glutamatergic neurotransmission in the nervous system|
MJ Niciu, B Kelmendi, G Sanacora
Pharmacology Biochemistry and Behavior 100 (4), 656-664, 2012
|NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia|
A Anticevic, M Gancsos, JD Murray, G Repovs, NR Driesen, DJ Ennis, ...
Proceedings of the National Academy of Sciences 109 (41), 16720-16725, 2012
|Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety|
ED Ballard, DF Ionescu, JLV Voort, MJ Niciu, EM Richards, ...
Journal of psychiatric research 58, 161-166, 2014
|Do the dissociative side effects of ketamine mediate its antidepressant effects?|
DA Luckenbaugh, MJ Niciu, DF Ionescu, NM Nolan, EM Richards, ...
Journal of affective disorders 159, 56-61, 2014
|Glutamate and gamma-aminobutyric acid systems in the pathophysiology of major depression and antidepressant response to ketamine|
MS Lener, MJ Niciu, ED Ballard, M Park, LT Park, AC Nugent, ...
Biological psychiatry 81 (10), 886-897, 2017
|Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review|
ND Iadarola, MJ Niciu, EM Richards, JL Vande Voort, ED Ballard, ...
Therapeutic advances in chronic disease 6 (3), 97-114, 2015
|Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds|
MJ Niciu, ID Henter, DA Luckenbaugh, CA Zarate Jr, DS Charney
Annual review of pharmacology and toxicology 54, 119-139, 2014
|Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder|
MJ Niciu, DF Ionescu, EM Richards, CA Zarate
Journal of neural transmission 121 (8), 907-924, 2014
|Neural correlates of change in major depressive disorder anhedonia following open-label ketamine|
N Lally, AC Nugent, DA Luckenbaugh, MJ Niciu, JP Roiser, CA Zarate Jr
Journal of psychopharmacology 29 (5), 596-607, 2015
|Neurobiology of anxious depression: a review|
DF Ionescu, MJ Niciu, DC Mathews, EM Richards, CA Zarate Jr
Depression and anxiety 30 (4), 374-385, 2013
|Developmental changes in the expression of ATP7A during a critical period in postnatal neurodevelopment|
MJ Niciu, XM Ma, R El Meskini, GV Ronnett, RE Mains, BA Eipper
Neuroscience 139 (3), 947-964, 2006
|Clinical predictors of ketamine response in treatment-resistant major depression|
MJ Niciu, DA Luckenbaugh, DF Ionescu, S Guevara, R Machado-Vieira, ...
The Journal of clinical psychiatry 75 (5), e417, 2014
|Examining the association between posttraumatic stress disorder and attention-deficit/hyperactivity disorder: a systematic review and meta-analysis|
AE Spencer, SV Faraone, OE Bogucki, AL Pope, M Uchida, MR Milad, ...
The Journal of clinical psychiatry 77 (1), 72-83, 2016
|The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial|
DL Boggs, T Surti, A Gupta, S Gupta, M Niciu, B Pittman, AMS Martin, ...
Psychopharmacology 235 (7), 1923-1932, 2018
|Defining anxious depression: a review of the literature|
DF Ionescu, MJ Niciu, ID Henter, CA Zarate Jr
CNS spectrums 18 (5), 252, 2013
|Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine|
DF Ionescu, DA Luckenbaugh, MJ Niciu, EM Richards, EE Slonena, ...
The Journal of clinical psychiatry 75 (9), 932-938, 2014
|Altered ATP7A expression and other compensatory responses in a murine model of Menkes disease|
MJ Niciu, XM Ma, R El Meskini, JS Pachter, RE Mains, BA Eipper
Neurobiology of disease 27 (3), 278-291, 2007
|Therapeutic modulation of glutamate receptors in major depressive disorder|
B A Jaso, M J Niciu, N D Iadarola, N Lally, E M Richards, M Park, ...
Current Neuropharmacology 15 (1), 57-70, 2017
|A single infusion of ketamine improves depression scores in patients with anxious bipolar depression|
DF Ionescu, DA Luckenbaugh, MJ Niciu, EM Richards, CA Zarate Jr
Bipolar disorders 17 (4), 438-443, 2015
|Targeted opioid receptor antagonists in the treatment of alcohol use disorders|
MJ Niciu, AJ Arias
CNS drugs 27 (10), 777-787, 2013